Published in Am J Hosp Pharm on February 01, 1980
Neurotoxicity induced by beta-lactam antibiotics: from bench to bedside. Eur J Clin Microbiol Infect Dis (2005) 1.16
Side effects of cephalosporins. Drugs (1987) 1.11
Inhibitory effect of cephalosporins on gamma-aminobutyric acid receptor binding in rat synaptic membranes. Antimicrob Agents Chemother (1985) 1.11
Animal model for evaluating the convulsive liability of beta-lactam antibiotics. Antimicrob Agents Chemother (1988) 1.03
Effects of renal function on the pharmacokinetics and pharmacodynamics of prophylactic cefazolin in cardiothoracic surgery. Eur J Clin Microbiol Infect Dis (2011) 0.78
Low neurotoxicity of LJC 10,627, a novel 1 beta-methyl carbapenem antibiotic: inhibition of gamma-aminobutyric acidA, benzodiazepine, and glycine receptor binding in relation to lack of central nervous system toxicity in rats. Antimicrob Agents Chemother (1993) 0.77
[Central nervous system side effects of different antibacterial substances]. Infection (1991) 0.75
Quality control of agar diffusion susceptibility tests. Am J Clin Pathol (1979) 8.11
Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial. Gut (1999) 2.44
Diastolic ventricular interaction in chronic heart failure. Lancet (1997) 2.27
Comparison of the electrophoretic karyotypes and chromosomal location of ten genes in the two varieties of Cryptococcus neoformans. Microbiology (1994) 2.14
Is there a chiropractic science? J Manipulative Physiol Ther (1990) 1.94
Treatment of achalasia: the best of both worlds. Am J Gastroenterol (1994) 1.82
Analytic clinical laboratory precision--state of the art for thirty-one analysis. Am J Clin Pathol (1980) 1.80
Sulfasalazine toxic reactions. Hepatitis, fever, and skin rash with hypocomplementemia and immune complexes. JAMA (1978) 1.49
Diastolic ventricular interaction: a possible mechanism for abnormal vascular responses during volume unloading in heart failure. Circulation (1997) 1.46
Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res (1994) 1.37
Diabetes and related metabolic risk factors among Arab Americans. Ann Pharmacother (1995) 1.36
Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects. Clin Pharmacol Ther (1989) 1.32
Quality-of-life assessment in cancer treatment protocols: research issues in protocol development. J Natl Cancer Inst (1992) 1.28
Characterization of the MFalpha pheromone of the human fungal pathogen cryptococcus neoformans. Mol Microbiol (2000) 1.27
Vancomycin pharmacokinetics in a patient population: effect of age, gender, and body weight. Ther Drug Monit (1994) 1.24
Alpha1-acid glycoprotein concentration and protein binding in trauma. Clin Pharmacol Ther (1982) 1.23
Proximal gastric vagotomy: effects of two operative techniques on clinical and gastric secretory results. Ann Surg (1976) 1.20
1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI). Bioorg Med Chem Lett (2001) 1.14
Circulating concentrations of di(2-ethylhexyl) phthalate and its de-esterified phthalic acid products following plasticizer exposure in patients receiving hemodialysis. Toxicol Appl Pharmacol (1985) 1.13
Tyzzer's Disease Syndrome in Laboratory Rabbits. Am J Pathol (1965) 1.12
The effect of renal failure on hepatic drug clearance. DICP (1991) 1.06
Natural infection of germfree rats with Mycoplasma pulmonis. J Infect Dis (1973) 1.05
Tyzzer's Disease of Rabbits: Isolation and Propagation of Bacillus piliformis (Tyzzer) in Embryonated Eggs. Infect Immun (1971) 1.03
Relationship of metal metabolism to vascular disease mortality rates in Texas. Am J Clin Nutr (1978) 1.01
Spontaneous Lancefield group G streptococcal infection in a random source cat colony. Lab Anim Sci (1973) 1.01
Tyzzer's disease. Am J Pathol (1971) 1.00
Isolation, propagation, and characterization of a newly recognized pathogen, cilia-associated respiratory bacillus of rats, an etiological agent of chronic respiratory disease. Infect Immun (1985) 1.00
Activities of beta-lactams against Acinetobacter genospecies as determined by agar dilution and E-test MIC methods. Antimicrob Agents Chemother (1997) 1.00
Parotid gland swelling developing during peroral endoscopy. Gastrointest Endosc (1975) 1.00
Factors influencing serum protein binding of lidocaine in humans. Anesth Analg (1981) 0.99
Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy. Am J Med (1987) 0.98
Inhibitors of bacterial enoyl acyl carrier protein reductase (FabI): 2,9-disubstituted 1,2,3,4-tetrahydropyrido[3,4-b]indoles as potential antibacterial agents. Bioorg Med Chem Lett (2001) 0.97
Restrictive left ventricular filling patterns are predictive of diastolic ventricular interaction in chronic heart failure. J Am Coll Cardiol (1998) 0.97
Chloramphenicol sodium succinate kinetics in critically ill patients. Clin Pharmacol Ther (1980) 0.96
Effects of ketoconazole on methylprednisolone pharmacokinetics and cortisol secretion. Clin Pharmacol Ther (1986) 0.96
Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity. Clin Pharmacol Ther (1991) 0.95
Submaxillary salivary gland swelling developing during peroral endoscopy. Gastroenterology (1969) 0.94
Assessing quality of life in head and neck cancer. Qual Life Res (1992) 0.92
Developing reimbursable clinical pharmacy programs: pharmacokinetic dosing service. Am J Hosp Pharm (1979) 0.92
Building quality of life assessment into cancer treatment studies. Oncology (Williston Park) (1992) 0.92
Busulfan levels are influenced by prior treatment and are associated with hepatic veno-occlusive disease and early mortality but not with delayed complications following marrow transplantation. Bone Marrow Transplant (2001) 0.90
Itraconazole and hydroxyitraconazole serum concentrations are reduced more than tenfold by phenytoin. Clin Pharmacol Ther (1995) 0.90
Appropriateness of the use of serum digoxin and digitoxin assays. Am J Hosp Pharm (1978) 0.89
Factors affecting quinidine protein binding in humans. J Pharm Sci (1984) 0.89
Endoscopic diagnosis of sliding-type diaphragmatic hiatal hernias. Am J Dig Dis (1968) 0.89
Chloramphenicol pharmacokinetics in hospitalized patients. Antimicrob Agents Chemother (1979) 0.88
Evaluation of dextrose 50 % as a medium for injection-assisted polypectomy. Endoscopy (2006) 0.88
A fatal infection in the opossum due to Mycobacterium intracellulare. J Infect Dis (1971) 0.88
Pharmacokinetics of ketoconazole administered intravenously to dogs and orally as tablet and solution to humans and dogs. J Pharm Sci (1986) 0.88
Comparison of pharmacokinetics and pharmacodynamics of short- and long-term glyburide therapy in NIDDM. Diabetes Care (1994) 0.87
Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma. Bone Marrow Transplant (2000) 0.86
Melioidosis in imported non-human primates. J Wildl Dis (1970) 0.85
The effects of a beta-2 selective adrenergic agonist and a beta-nonselective antagonist on theophylline clearance. J Clin Pharmacol (1987) 0.84
Displacement of lidocaine from serum alpha 1-acid glycoprotein binding sites by basic drugs. Eur J Clin Pharmacol (1983) 0.84
The effect of stress on glycemic control in patients with type II diabetes during glyburide and glipizide therapy. J Clin Pharmacol (1993) 0.83
The pharmacokinetics of meperidine in acute trauma patients. J Trauma (1986) 0.83
Portal vein thrombosis resulting in portal hypertension in adults. Am J Gastroenterol (1976) 0.83
Effect of smoking on binding of lidocaine to human serum proteins. J Pharm Sci (1980) 0.82
Diastolic ventricular interaction in chronic heart failure: relation to heart rate variability and neurohumoral status. Heart Vessels (1998) 0.82
The pharmacy computer system at The Ohio State University hospitals. Am J Hosp Pharm (1984) 0.81
Lack of effect of smoking on the metabolism and pharmacokinetics of quinidine in patients. Br J Clin Pharmacol (1987) 0.81
Gentamicin in ascitic fluid. Ann Intern Med (1979) 0.81
Susceptibilities of nontuberculosis mycobacterial species to amoxicillin-clavulanic acid alone and in combination with antimycobacterial agents. Antimicrob Agents Chemother (1995) 0.81
Steroid dose sparing: pharmacodynamic responses to single versus divided doses of methylprednisolone in man. J Allergy Clin Immunol (1990) 0.81
Cloning, sequence analysis and expression of the gene encoding imidazole glycerol phosphate dehydratase in Cryptococcus neoformans. Gene (1994) 0.80
The mathematical relationship of drinking water lithium and rainfall to mental hospital admission. Dis Nerv Syst (1970) 0.80
Use of concurrent monitoring and a preprinted note to modify prescribing of i.v. cimetidine and ranitidine in a teaching hospital. Am J Hosp Pharm (1989) 0.79
Lack of effect of atenolol on the pharmacokinetics of theophylline. Br J Clin Pharmacol (1988) 0.79
Total and unbound concentrations of quinidine and 3-hydroxyquinidine at steady state. Am Heart J (1987) 0.79
Latent Pasteurella pneumotropica infection of the gnotobiotic and barrier-held rats. Lab Anim Sci (1973) 0.79
Simultaneous analysis of methylprednisolone hemisuccinate, cortisol and methylprednisolone by normal-phase high-performance liquid chromatography in human plasma. J Chromatogr (1988) 0.79
Multiple bolus technique for lidocaine administration in acute ischemic heart disease. II. Treatment of refractory ventricular arrhythmias and the pharmacokinetic significance of severe left ventricular failure. J Am Coll Cardiol (1983) 0.78
Managing employee apprehension toward handling cytotoxic drugs. Am J Hosp Pharm (1985) 0.78
Cytomegalovirus prophylaxis and treatment following bone marrow transplantation. Ann Pharmacother (1996) 0.78
Ketoconazole effects on methylprednisolone disposition and their joint suppression of endogenous cortisol. Clin Pharmacol Ther (1987) 0.78
Controlled trial of orally administered immunoglobulin following bone marrow transplantation. Bone Marrow Transplant (1994) 0.78
Cecocolitis in immunodeficient mice associated with an enteroinvasive lactose negative E. coli. Lab Anim Sci (1988) 0.78
High-performance liquid chromatographic procedure for the determination of di-(2-ethylhexyl)phthalate in human blood specimens. Problems of variable-extraction yield and the use of standard addition for calibration. J Chromatogr (1984) 0.78
Relationship of lithium metabolism to mental hospital admission and homicide. Dis Nerv Syst (1972) 0.78
Correlation of lower esophageal sphincter pressure and serum gastrin level in man. Am J Dig Dis (1975) 0.77
The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus. Pharmacotherapy (1997) 0.77
The pharmacokinetics and pharmacodynamics of 12 weeks of glyburide therapy in obese diabetics. Eur J Clin Pharmacol (1993) 0.77
The influence of early transplantation, age, GVHD prevention regimen, and other factors on outcome of allogeneic transplantation for CML following BuCy. Bone Marrow Transplant (2000) 0.76
Forearm vasoconstriction during dynamic leg exercise in patients with chronic heart failure. Heart Vessels (1998) 0.76
The translation initiation site of recombinant Trypanosoma brucei ornithine decarboxylase varies with different promoters. Mol Biochem Parasitol (1992) 0.76
Effect of laminar air flow and clean-room dress on contamination rates of intravenous admixtures. Am J Hosp Pharm (1981) 0.76
Effect of multidose therapy on cerebrospinal fluid penetration of cefazolin. Am J Hosp Pharm (1981) 0.76
Mobilization of peripheral-blood progenitor cells with high-dose etoposide and granulocyte colony-stimulating factor in patients with breast cancer, non-Hodgkin's lymphoma, and Hodgkin's disease. J Clin Oncol (1997) 0.76
Quality control of agar diffusion susceptibility tests. Data from the Quality Assurance Service Microbiology Program of the College of American Pathologists. Am J Clin Pathol (1980) 0.76
New chemotherapeutic agents for breast cancer. Cancer (1994) 0.75
Analysis of prognostic factors for allogeneic marrow transplantation following busulfan and cyclophosphamide in myelodysplastic syndrome and after leukemic transformation. Bone Marrow Transplant (2000) 0.75
Phase II trials of small-cell lung cancer. J Clin Oncol (1992) 0.75
Endotoxin levels in adult liver donors. Aust N Z J Surg (1994) 0.75
Relationship between serum and saliva chloramphenicol concentrations. Antimicrob Agents Chemother (1979) 0.75
The pharmacokinetics and pharmacodynamics of quinidine and 3-hydroxyquinidine. Br J Clin Pharmacol (1988) 0.75
Blood sampling errors: a problem and challenge for therapeutic drug monitoring services. Drug Intell Clin Pharm (1985) 0.75
Hepatic drug clearance following traumatic injury. Drug Intell Clin Pharm (1985) 0.75
Severe theophylline toxicity. Am J Med (1985) 0.75
Viral infections of the liver. Ala J Med Sci (1985) 0.75